How to Get Rich (without getting lucky):
More from Life
Okay hope everyone having a lovely weekend. Lots of love today. Feeling very blessed 🥰 Going through NNOX tweets from last week. Time to compile threads and bring you highlights. No need to go digging old tweets if I do for you 🤗 FDA, Secondary, and 3P510k. Let’s review..
The NNOX news flow been exceptionally good. I tweet about Fear Uncertainty Doubt and how short sellers leverage friction in news flow to mine some of your gains. NNOX published Form F-1/A to remove friction. Investors have answers.
Form F-1/A Link:
Form F-1 is over 200 detailed pages. Very concentrated. Everything you need for rest of this month in the document. A few notes for you. NNOX FDA approval uses a third party review organization in 510k process. This is abbreviated to 3P510k.
I covered the 3P510K in thread here: https://t.co/w7zE882CVk
Reference to Eagle eyes: https://t.co/gT779MFX82
We discover in F-1 that 3P510K recommended clearance of Nanox Source. This triggers a 30 day timeline to approval by FDA. However ...
Look at you favorite broker news for NNOX. I look at 3 different broker none of them comment NNOX from 60 to 80 on news that 3P510k recommended FDA approve NNOX device. NNOX get a letter and slide 10% we get headline. But no headline for big pop 🤷♂️ that’s the friction.
The NNOX news flow been exceptionally good. I tweet about Fear Uncertainty Doubt and how short sellers leverage friction in news flow to mine some of your gains. NNOX published Form F-1/A to remove friction. Investors have answers.
Form F-1/A Link:
Form F-1 is over 200 detailed pages. Very concentrated. Everything you need for rest of this month in the document. A few notes for you. NNOX FDA approval uses a third party review organization in 510k process. This is abbreviated to 3P510k.
I covered the 3P510K in thread here: https://t.co/w7zE882CVk
Reference to Eagle eyes: https://t.co/gT779MFX82
We discover in F-1 that 3P510K recommended clearance of Nanox Source. This triggers a 30 day timeline to approval by FDA. However ...
Eagle-eyes \U0001f985 https://t.co/w1wF3Ysmt1
— Harvey \U0001f1fa\U0001f1f8 (@realharveymark) February 12, 2021
Look at you favorite broker news for NNOX. I look at 3 different broker none of them comment NNOX from 60 to 80 on news that 3P510k recommended FDA approve NNOX device. NNOX get a letter and slide 10% we get headline. But no headline for big pop 🤷♂️ that’s the friction.
You May Also Like
https://t.co/6cRR2B3jBE
Viruses and other pathogens are often studied as stand-alone entities, despite that, in nature, they mostly live in multispecies associations called biofilms—both externally and within the host.
https://t.co/FBfXhUrH5d
Microorganisms in biofilms are enclosed by an extracellular matrix that confers protection and improves survival. Previous studies have shown that viruses can secondarily colonize preexisting biofilms, and viral biofilms have also been described.
...we raise the perspective that CoVs can persistently infect bats due to their association with biofilm structures. This phenomenon potentially provides an optimal environment for nonpathogenic & well-adapted viruses to interact with the host, as well as for viral recombination.
Biofilms can also enhance virion viability in extracellular environments, such as on fomites and in aquatic sediments, allowing viral persistence and dissemination.
Viruses and other pathogens are often studied as stand-alone entities, despite that, in nature, they mostly live in multispecies associations called biofilms—both externally and within the host.
https://t.co/FBfXhUrH5d
Microorganisms in biofilms are enclosed by an extracellular matrix that confers protection and improves survival. Previous studies have shown that viruses can secondarily colonize preexisting biofilms, and viral biofilms have also been described.
...we raise the perspective that CoVs can persistently infect bats due to their association with biofilm structures. This phenomenon potentially provides an optimal environment for nonpathogenic & well-adapted viruses to interact with the host, as well as for viral recombination.
Biofilms can also enhance virion viability in extracellular environments, such as on fomites and in aquatic sediments, allowing viral persistence and dissemination.